LENSAR Inc logo

LENSAR Inc

LNSR | NASDAQ
Chart Builder DCF Calculator
$7.29
+$0.08 (+1.11%)
Sep 22, 2026, 11:08 AM ET · Market open

Company Profile

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Key Executives

Name Position
Nicholas T. Curtis President, Chief Executive Officer & Director
Alan Connaughton Chief Operating Officer
Kendra W. Wong Principal Accounting Officer
Michael A. Rossi Interim CFO & Principal Financial Officer and Secretary

Latest SEC Filings

Date Type Title
Aug 13, 2026 10-Q Quarterly Report
Aug 13, 2026 8-K Current Report
Aug 10, 2026 8-K Current Report
Jul 29, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jun 23, 2026 DEFA14A Filing
Jun 23, 2026 ARS Filing
Jun 23, 2026 DEF 14A Filing
Jun 05, 2026 4 Filing
Jun 05, 2026 4 Filing
Jun 05, 2026 4 Filing
View All SEC Filings
LENSAR Inc
LENSAR Inc logo
Country United States
IPO Date Oct 1, 2020
Industry Medical - Devices
Sector Healthcare
Employees 150
CEO Nicholas T. Curtis

Contact Details

2800 Discovery Drive Orlando, Florida 32826 United States

Stock Details

Ticker Symbol LNSR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001320350
CUSIP Number 52634L108
ISIN Number US52634L1089
SIC Code 3841

© 2026 bestshares.com. All rights reserved.